Table 4: Investigation of risk factors associated with the demographic and disease-related characteristics features of RA individuals who are in the active period (low or moderate-high disease activity) according to DAS 28.
|
Variables |
Remission and low disease activity |
Remission and moderate-high disease activity |
Low and moderate-high disease activity |
|||
|
|
OR (95% CI) |
p* |
OR (95% CI) |
p* |
OR (95% CI) |
p* |
|
Gender (Female/Male) |
0.93 (0.40 - 2.16) |
0.880 |
1.67 (0.77 - 3.63) |
0.139 |
1.42 (0.75 - 2.69) |
0.179 |
|
BMI (Normal/Owerweight) |
0.50 (0.21 - 1.23) |
0.111 |
0.72 (0.45 - 1.17) |
0.173 |
1.10 (0.79 - 1.53) |
0.569 |
|
Duration of disease (Early stage/late stage) |
0.93 (0.41 - 2.06) |
0.859 |
1.66 (0.76 - 1.78) |
0.489 |
1.11 (0.82 - 1.52) |
0.497 |
|
Morning stiffness (≤ 60 sec/> 60 sec) |
0.48 (0.21 - 1.06) |
0.112 |
0.53 (0.36 - 0.79) |
0.013 |
0.91 (0.64 - 1.30) |
0.648 |
|
Presence of deformity (Yes/No) |
1.50 (0.75 - 2.99) |
0.259 |
1.56 (1.05 - 2.32) |
0.031 |
1.09 (0.80 - 1.47) |
0.581 |
|
Presence of nodules (Yes/No) |
0.73 (0.20 - 2.67) |
0.628 |
1.62 (1.08 - 2.42) |
0.037 |
1.38 (1.05 - 1.80) |
0.065 |
|
Dry eye (Yes/No) |
0.80 (0.392 - 1.63) |
0.537 |
1.12 (0.74 - 1.69) |
0.571 |
1.17 (0.86 - 1.58) |
0.310 |
|
Nail abnormalities (Yes/No) |
0.93 (0.41 - 2.06) |
0.859 |
1.05 (0.67 - 1.65) |
0.811 |
1.06 (0.76 - 1.47) |
0.727 |
|
Raynaud's phenomenon (Yes/No) |
1.93 (0.96 - 3.86) |
0.082 |
1.53 (1.02 - 2.31) |
0.065 |
0.96 (0.68 - 1.37) |
0.839 |
|
Osteoporosis (Yes/No) |
0.80 (0.31 - 2.05) |
0.634 |
1.97 (1.32 - 2.94) |
0.001 |
1.55 (1.15 - 2.09) |
0.006 |
|
Dyspnea at rest (Yes/No) |
0.54 (0.14 - 2.04) |
0.331 |
1.45 (0.95 - 2.19) |
0.104 |
1.40 (1.08 - 1.82) |
0.046 |
|
Exertional dyspnea (Yes/No) |
1.19 (0.60 - 2.39) |
0.611 |
1.64 (1.08 - 2.48) |
0.017 |
1.22 (0.89 - 1.68) |
0.193 |
OR: Odds Ratio, CI: Confidence Interval, *Pearson Chi-square test.